Amarin Corporation

AMRN | NASDAQ

Price Alert Chart Builder DCF Calculator

$13.56

-$0.07 (-0.51%)

Sep 21, 2026, 10:19 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.51%

(1D)

Rating

Updated: Aug 24, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $280.46M

1D Range

13.54 13.80

52W Range

12.96 20.90

Valuation (TTM)

PE -14.20

PB 0.64

EV/EBITDA 1.34

Valuation (NTM)

Forward PE 274.94

Forward PEG 0.22

Price Target $2.17

Cash Flow

FCF Yield 17.4%

SBC Adj. FCF Yield 20.2%

SBC Impact -16.1%

Margins

Gross Margin 41.6%

Operating Margin -18.1%

FCF Margin 26.7%

Growth (CAGR)

Revenue 3Y | 5Y -18.9% | -21.6%

Dil EPS 3Y | 5Y 13.7% | 16.7%

FCF 3Y | 5Y 209.0% | 144.3%

Returns

ROA -4.3%

ROE -6.0%

ROIC -7.3%

Financial Health

Net Cash

$309.39M

Current Ratio 3.67

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several internat...

Sector Healthcare

Industry Drug Manufacturers - General

Employees 80

IPO Date Mar 31, 1993

Website www.amarincorp.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞